Nashville, Tenn.-based Vanderbilt University Medical Center has partnered with Bayer to advance therapeutics for the treatment of cardiovascular and kidney diseases.
The collaboration will last five years through an Investigational New Drug application, according to a Jan. 20 news release from VUMC.
The partnership aims to leverage clinical expertise and biological datasets alongside Bayer’s drug development portfolio to accelerate drug discovery, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
